OxySure Earnings Presentation - 1Q2014 v2.pdf May. 2014 | Page 3

1Q 2014 Financial Highlights • Revenues were $356,229, up 48% • Sales & marketing expense down 18% • Research & development expense down 96% • G&A expense up 35% • Notes payable slightly up by $25,843 to $375,818 • Net loss per share flat at $.01 for the quarter • Cartridge shipments increased 201% 3